Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »

Market Forecasts

Moody's Raises U.S. Medical Device Market Rating from Stable to Positive BY ANDREW VAHRADIAN, AUGUST 20, 2015

Moody's Investors Service has raised its outlook for the U.S. medical products and devices industry from "Stable" to "Positive" due to sector mergers and acquisitions (M&A), the commercialization of new products, and an uptick in growth of hospital admissions. In... more

Study Demonstrates Joint Replacement Procedures are "Recession-proof" BY ANDREW VAHRADIAN, APRIL 11, 2014

A new study published in the Journal of Bone and Joint Surgery (JBJS), concluded that the economic recessions experienced in the 21st century up to this point, have not substantially hindered the growth trends for hip and knee arthroplasty in... more

Drug Device Combination Product Market to Grow to $115B BY ANDREW VAHRADIAN, JANUARY 7, 2014

According to a new report from Transparency Market Research, the global market for drug device combination products is anticipated to grow from $66 billion in 2012 to $115.1 billion by 2019. According to the FDA, drug device combination products are... more

Growth of the Consumer Medical Device Marketplace Expected to Increase BY ANDREW VAHRADIAN, OCTOBER 3, 2013

A new report from IHS Inc. determined that as the "baby boomers" generation ages and the health care industry evolves into a system that emphasizes wellness and prevention, the global market for consumer medical devices will grow to more than... more

Positive Outlook Predicted for European Medtech Industry BY ANDREW VAHRADIAN, AUGUST 1, 2013

Through various market reports, researchers and industry professionals are predicting an overall positive outlook for the medtech industry in the European Union. The European Medtech Market is estimated at a size of €100 billion ($133 billion) and is growing approximately... more

Maryland's Emerging Medtech Industry BY ANDREW VAHRADIAN, JULY 25, 2013

The state of Maryland normally goes unnoticed in regards to the medtech and bioscience sectors when compared to California, Massachusetts and Minnesota. However, the state has the research facilities, governmental institutions and programs, corporate partnerships, funding and ambition to advance... more

Medical Device Sector Projected to Grow in Taiwan BY ANDREW VAHRADIAN, MAY 30, 2013

According to a recent study published by the Industry and Technology Intelligence Services (ITIS), a research institute of Taiwan's Ministry of Economic Affairs, the production value of the medical device sector in Taiwan is expected to grow 7.1% in 2013... more

Chinese Governmental Expenditure on Healthcare Anticipated to Rise BY ANDREW VAHRADIAN, APRIL 25, 2013

Two independent industry reports illustrate encouraging signs regarding the development of the healthcare industry in China, indicating that healthcare spending in the country will increase substantially in future years. Industry analysts at KPMG anticipate that Chinese governmental expenditure on pharmaceuticals,... more

Medical Device Industry Recognizes Significant Gains in Total M&A Value during 2012 BY ANDREW VAHRADIAN, APRIL 2, 2013

The latest Pharmaceutical and Life Sciences Deals Insights quarterly report from PricewaterhouseCoopers (PwC) revealed a slight year-over-year decrease in transaction volume in the medtech sector, but noted that the sector's M&A market experienced its largest-ever rise in total value. PwC... more

Hospital Capital Expenditures Continue to Improve BY SANDER DUNCAN, JANUARY 27, 2011

Hospital capital expenditures are a leading indicator of hospital profitability, financial health and overall purchasing ability. During tough times, hospitals scale back on equipment purchases and facilities expansion -- sometimes dramatically. During the 2008 liquidity crisis, draconian capital expenditure reductions... more

"Scorecard" for Device Markets Forthcoming from PWC BY LAUREN UZDIENSKI, MAY 12, 2010

pwc.gifPricewaterhouseCoopers announced that they're working on an "independent study of international market conditions for medical device innovation" in the key markets of Brazil, China, France, Germany, Israel, India, Japan, United Kingdom and the United States. PWC will score each region's device climate based on regulatory policy, patient access to technologies, demographics and "market factors." more

Dental News Roundup January 2010 BY LAUREN UZDIENSKI, JANUARY 28, 2010

We're listening. In response to your feedback on our 2009 readership survey, we're broadening the dental coverage on our blog. You can help by letting us know what you think or directing your press releases and scientific articles to Lauren... more

Looming Tantalum Shortage May Impact Orthopedic Devices BY LAUREN UZDIENSKI, SEPTEMBER 29, 2009

A new report from Roskill Information Services predicts a worldwide shortage of tantalum, a porous metal used in coating orthopedic devices. Tantalum has been demonstrated to facilitate a bond between an implant and the surrounding bone, with additional benefits including... more

Early Earnings Reports Show Growth Despite Economy BY LAUREN UZDIENSKI, APRIL 16, 2009

DePuy and Biomet have kicked off 1Q earnings season on a positive note, offering a view of industry growth that may be outpacing expectations. These two companies, which together comprise more than a third of the ortho market, reported 7%... more

While Some Sectors Struggle, Early 4Q Results Show Stability for Ortho BY LAUREN UZDIENSKI, JANUARY 14, 2009

Over the weekend, posted a report on some of the reasons why the healthcare industry may be more vulnerable to a recession now than in the past. However, the article also helped to highlight the ways in which orthopedics... more

Orthopedic News Roundup 29-Mar-07 BY LAUREN UZDIENSKI, MARCH 29, 2007

Earnings BioMimetic Therapeutics announced 4Q:06 financial results, reporting a net loss of $5.3 million or $0.34 per share and beating analysts' estimates of a loss of $0.37 per share. This compares to a net loss of $9.2 million, or $5.82... more

Orthopedics: It's About Earnings BY JOHN MCCORMICK, DECEMBER 13, 2006

We are frequently asked this question: why do orthopedic medical device companies lose money in the initial stages of their development? The short answer is that it is a deliberate decision by management teams to grow their companies' revenues. The... more

1Q:06 Final Performance Summary BY HUYEN NGUYEN, MAY 25, 2006

Final results for the 26 publicly-traded orthopedic companies* in 1Q:06 showed that orthopedic sales for first quarter increased by 9.2%, as reported. Now that Medtronic has reported its spine revenues, total aggregated sales for those 26 companies came in at... more

Medical Device Trade in Foreign Markets -- Investigation BY HUYEN NGUYEN, APRIL 5, 2006

The U.S. International Trade Commission (ITC) issued a press release yesterday announcing the launch of a fact-finding investigation into conditions affecting U.S. trade of medical devices and equipment in principal foreign markets, particularly the Japanese market. The House Ways and... more

Another Take on Forecasting the Orthopedic Market BY DAVID KRESSEL, MARCH 29, 2006

At AAOS last week, representatives of Exponent Inc., an engineering and scientific consulting firm, presented a study forecasting growth in the orthopedic market. Whereas our market forecast focused on revenue over the next few years, this study looks at unit... more

Spine Segment Outlook BY JOHN MCCORMICK, FEBRUARY 22, 2005

HealthpointCapital, LLC research has initiated a new program of making our market forecasts of the several orthopedic medical device segments available to our subscribers. This article, the first of a series, summarizes our spine market forecast which comes from our... more

We Pause to Examine the Large Joint Market Ahead of the Conclusion of Earnings Season BY JOHN CHOPACK, JULY 19, 2004

With DePuy, Stryker and Biomet reporting during the last three weeks, this is a good time to identify specific topics imperative to the remainder of the sector's earnings releases over the next several weeks. Large Joint Companies Earnings 2Q:04 Reports... more

2004 Orthopedic Industry Outlook: 15% revenue growth to $20 billion BY EDITOR, DECEMBER 15, 2003

For the past three weeks the HealthpointCapital research staff has been preparing a detailed outlook for the Orthopedic Industry with special emphasis on Large Joint Reconstruction, Spinal Implants, Sports Medicine (including bracing) and Biologics. The result is our outlook for... more

Biomet's Announcement Offers 3rd Quarter Preview BY EDITOR, SEPTEMBER 22, 2003

What makes the Orthopedic Industry's current renaissance so interesting is not only how unexpected it is, but how unexpectedly broad and deep it is. Unlike the cardiovascular industry, which is riding the drug coated stent phenomenon, orthopedic revenues are bubbling... more

HealthpointCapital Initiates Research Coverage of Exactech, Inc. and Regeneration Technologies BY EDITOR, MAY 5, 2003

Last week we published our sales and earnings forecast as well as an analysis of future prospects for two companies, Exactech and Regeneration Technologies. We've posted the summary of our analysis for each company on First Call (the Thompson Financial... more

Complete Archive